High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes (Q39993447)

16 September 2017

title

High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes (English)

1 reference

16 September 2017

0 references

1 reference

Katarzyna Krzyzanowska

1

1 reference

16 September 2017

Yoshimasa Aso

2

1 reference

16 September 2017

Friedrich Mittermayer

3

1 reference

16 September 2017

Toshihiko Inukai

4

1 reference

16 September 2017

Johanna Brix

5

1 reference

16 September 2017

Guntram Schernthaner

6

1 reference

16 September 2017

publication date

28 February 2009

1 reference

16 September 2017

published in

Translational Research

1 reference

16 September 2017

volume

153

1 reference

16 September 2017

issue

4

1 reference

16 September 2017

page(s)

199-203

1 reference

Adiponectin, obesity, and cardiovascular disease

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

AdipoQ is a novel adipose-specific gene dysregulated in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Adiponectin: more than just another fat cell hormone?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Plasma adiponectin levels and risk of myocardial infarction in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Diagnosis and classification of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Performance of ELISA for specific measurement of high-molecular-weight (HMW) adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Adiponectin and Coronary Heart Disease: The Strong Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Adiponectin and Coronary Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

The role of total and high-molecular-weight complex of adiponectin in vascular function in offspring whose parents both had type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.01.009

10.1016/J.TRSL.2009.01.009

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference